Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Tetrodotoxin
×
Clear all
Filters
2
NCT00725114
2014-07-09
TEC-006
Wex Pharmaceuticals Inc.
Phase 3
Completed
165 enrolled
NCT00726011
2012-10-24
TEC-006OL
Wex Pharmaceuticals Inc.
Phase 3
Completed
113 enrolled